GPC
CLPT icon

Guardian Point Capital’s ClearPoint Neuro CLPT Stock Holding History

Guardian Point Capital’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$1.12M – 16
2021
Q4 		$1.12M Sell
100,000
-130,000
-57% -$1.95M 0.26% 17
2021
Q3 		$4.08M Buy
+230,000
New +$4.31M 0.95% 18

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Guardian Point Capital's CLPT Position: Q1 2022 in Review

Guardian Point Capital sold out of ClearPoint Neuro (CLPT) in Q1 2022, closing a stake of 100,000 shares — an estimated $1.12M sold.

Guardian Point Capital first reported a position in CLPT in Q3 2021 and held it in 2 quarters. The position peaked at $4.08M in Q3 2021. 64 funds tracked by Wall St. Rank hold CLPT as of Q1 2022.

  • Guardian Point Capital reported no remaining ClearPoint Neuro position as of Q1 2022 after selling out during the quarter.
  • Guardian Point Capital sold 100,000 ClearPoint Neuro shares in Q1 2022, an estimated $1.12M.
  • Guardian Point Capital first reported a position in ClearPoint Neuro in Q3 2021 and held it in 2 quarters.
  • Guardian Point Capital's ClearPoint Neuro position peaked at $4.08M in Q3 2021.
  • 64 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2022.

Based on Guardian Point Capital's 13F filing for Q1 2022, filed 16 May 2022.